Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Innovotech Inc. (V:IOT)

Business Focus: Biotechnology & Medical Research

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for IOT within the last 6 months
See all filings within the past 6 months

Company News

May 28, 2020 03:05 ET
Innovotech Inc. Reports Financial Results for the 1st Quarter Ended March 31, 2020
Edmonton – TheNewswire - May 28th, 2020.  Innovotech Inc (TSXV:IOT) has released its financial and operating results for the first quarter of the 2020 year.  In the three months to March 31st, the Company incurred a loss of $115,298 on reduced revenue of $126,387.  The net loss is directly related to the lower revenue.  The lower revenue is related to client supply chain issues connected to the COVID-19 pandemic.  Those issues delayed signed research contracts, which were required to be deferred or delayed into the second quarter.  
Read full article
Apr 28, 2020 04:04 ET
Innovotech Reports 2019 Financial Results
Edmonton – TheNewswire - April 28, 2020 - Innovotech (TSXV:IOT) recorded a 19% increase in revenue to $986,225 in the year ended December 31, 2019, an increase of $159,290 over the prior year. Contract research fees increased to $693,612 from $579,472 and sales of the MBEC assay kit rose to $292,613 from $247,463.  Increased revenue resulted in a gross profit of $695,113, up from $606,321 in the prior year.
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jun 30, 20208,026-12,462
Jun 15, 202020,48820,337
May 31, 2020151-2,000
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Innovotech Inc is a Canada-based company, which operates in the field of biofilm product development, practical services and solutions for dealing with medical, agricultural and industrial problems caused by microbial biofilms. The Company's current products include human and veterinary biofilm susceptibility tests, a seed treatment designed to combat both bacterial and fungal diseases, and an assay used in growing microbal biofilms for research purposes. The Company's products are effective against such diseases as Powdery Mildew on lettuce, White Mould on beans, Bacterial Spot on tomatoes and Fire Blight on apples. The Company's products include InnovoSIL, MBEC Assay Agress and AgreGuard.

See business summary



Search (past week) for $IOT.CA IOT.V

  • No tweets found